BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3033127)

  • 1. Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients.
    Tugwood JD; Lau WH; O SK; Tsao SY; Martin WM; Shiu W; Desgranges C; Jones PH; Arrand JR
    J Gen Virol; 1987 Apr; 68 ( Pt 4)():1081-91. PubMed ID: 3033127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma.
    Sam CK; Brooks LA; Niedobitek G; Young LS; Prasad U; Rickinson AB
    Int J Cancer; 1993 Apr; 53(6):957-62. PubMed ID: 8386141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus in oropharyngeal and nasopharyngeal secretions of patients with nasopharyngeal carcinoma and control subjects.
    Tsao SY; He Y; Cheng PM; Ho S; Leung SF; Chang RS
    Intervirology; 1991; 32(4):209-15. PubMed ID: 1650762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign and malignant disease caused by EBV.
    Wolf H; Seibl R
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):88s-95s. PubMed ID: 6330230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt's lymphoma, nasopharyngeal carcinoma, infectious mononucleosis and the Epstein-Barr virus.
    Strauss M
    Laryngoscope; 1972 Nov; 82(11):2049-58. PubMed ID: 4343097
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection.
    Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF
    Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus transcription in nasopharyngeal carcinoma.
    Raab-Traub N; Hood R; Yang CS; Henry B; Pagano JS
    J Virol; 1983 Dec; 48(3):580-90. PubMed ID: 6313960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
    Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
    Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus DNA in nasopharyngeal biopsies.
    Zhang HY; Qu G; Deng ZW; Yao TH; Glaser R
    Virus Res; 1989 Jan; 12(1):53-9. PubMed ID: 2541582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.
    Bornkamm GW; Delius H; Zimber U; Hudewentz J; Epstein MA
    J Virol; 1980 Sep; 35(3):603-18. PubMed ID: 6252328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus infections. New pathogenic and clinical aspects].
    Wilmes E; Wolf H
    Laryngorhinootologie; 1989 Jan; 68(1):36-43. PubMed ID: 2536874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma.
    Shimakage M; Chatani M; Ikegami N; Hirai K
    Jpn J Cancer Res; 1989 Jul; 80(7):612-6. PubMed ID: 2551868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome.
    Sato H; Takimoto T; Hatano M; Pagano JS; Raab-Traub N
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():717-27. PubMed ID: 2543756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.
    Brooks LA; Lear AL; Young LS; Rickinson AB
    J Virol; 1993 Jun; 67(6):3182-90. PubMed ID: 8388496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.
    Sugden B
    Rev Infect Dis; 1982; 4(5):1048-61. PubMed ID: 6293034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo.
    Gilligan KJ; Rajadurai P; Lin JC; Busson P; Abdel-Hamid M; Prasad U; Tursz T; Raab-Traub N
    J Virol; 1991 Nov; 65(11):6252-9. PubMed ID: 1656092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.